These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 8353071)
41. Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia. Field K; Slavin MA; Seymour JF Eur J Haematol; 2002 Jul; 69(1):54-7. PubMed ID: 12270063 [TBL] [Abstract][Full Text] [Related]
42. Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine. Juliusson G; Elmhorn-Rosenborg A; Liliemark J N Engl J Med; 1992 Oct; 327(15):1056-61. PubMed ID: 1355853 [TBL] [Abstract][Full Text] [Related]
43. Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease. Khouri IF; Przepiorka D; van Besien K; O'Brien S; Palmer JL; Lerner S; Mehra RC; Vriesendorp HM; Andersson BS; Giralt S; Körbling M; Keating MJ; Champlin RE Br J Haematol; 1997 May; 97(2):466-73. PubMed ID: 9163617 [TBL] [Abstract][Full Text] [Related]
44. Fludarabine combined with cyclophosphamid is highly effective in the treatment of chronic lymphocytic leukemia. Tóthová E; Kafková A; Fricová M; Guman T; Stecová N Neoplasma; 2003; 50(6):433-7. PubMed ID: 14689065 [TBL] [Abstract][Full Text] [Related]
45. A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemia. Robertson LE; O'Brien S; Kantarjian H; Koller C; Beran M; Andreeff M; Lerner S; Plunkett W; Keating MJ Leukemia; 1995 Sep; 9(9):1444-9. PubMed ID: 7658710 [TBL] [Abstract][Full Text] [Related]
46. A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia. Hocepied AM; Falkson CI; Falkson G S Afr Med J; 1996 May; 86(5):549-50. PubMed ID: 8711555 [TBL] [Abstract][Full Text] [Related]
48. Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia. Faderl S; Rai K; Gribben J; Byrd JC; Flinn IW; O'Brien S; Sheng S; Esseltine DL; Keating MJ Cancer; 2006 Sep; 107(5):916-24. PubMed ID: 16832816 [TBL] [Abstract][Full Text] [Related]
49. Eosinophilia during fludarabine treatment of chronic lymphocytic leukemia. Sezer O; Schmid P; Hallek M; Schweigert M; Beinert T; Langelotz C; Mergenthaler HG; Possinger K Ann Hematol; 1999 Oct; 78(10):475-7. PubMed ID: 10550560 [TBL] [Abstract][Full Text] [Related]
50. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. Cheson BD; Vena DA; Barrett J; Freidlin B J Clin Oncol; 1999 Aug; 17(8):2454-60. PubMed ID: 10561309 [TBL] [Abstract][Full Text] [Related]
51. Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia. Schmitt B; Wendtner CM; Bergmann M; Busch R; Franke A; Pasold R; Schlag R; Hopfinger G; Hiddemann W; Emmerich B; Hallek M Clin Lymphoma; 2002 Jun; 3(1):26-35. PubMed ID: 12141952 [TBL] [Abstract][Full Text] [Related]
52. Flare-up of squamous cell carcinoma of the skin following fludarabine therapy for chronic lymphocytic leukemia. Davidovitz Y; Ballin A; Meytes D Acta Haematol; 1997; 98(1):44-6. PubMed ID: 9210914 [TBL] [Abstract][Full Text] [Related]
53. Present status of purine analogs in the therapy of chronic lymphocytic leukemias. Bergmann L Leukemia; 1997 Apr; 11 Suppl 2():S29-34. PubMed ID: 9178835 [TBL] [Abstract][Full Text] [Related]
54. Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: a phase II study. Giles FJ; O'Brien SM; Santini V; Gandhi V; Plunkett W; Seymour JF; Robertson LE; Kantarjian HM; Keating MJ Leuk Lymphoma; 1999 Dec; 36(1-2):57-65. PubMed ID: 10613450 [TBL] [Abstract][Full Text] [Related]
55. [Acquired pure red cell aplasia in a patient with B cell chronic lymphocytic leukemia after fludarabine therapy]. Tsuji T; Hirano T; Yamasaki H; Tuda H Rinsho Ketsueki; 2015 Jun; 56(6):705-10. PubMed ID: 26256883 [TBL] [Abstract][Full Text] [Related]
56. Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997. Flinn IW; Neuberg DS; Grever MR; Dewald GW; Bennett JM; Paietta EM; Hussein MA; Appelbaum FR; Larson RA; Moore DF; Tallman MS J Clin Oncol; 2007 Mar; 25(7):793-8. PubMed ID: 17283364 [TBL] [Abstract][Full Text] [Related]
57. Fludarabine in untreated and previously treated B-CLL patients: a report on efficacy and toxicity. Spriano M; Clavio M; Carrara P; Canepa L; Miglino M; Pierri I; Celesti L; Rossi E; Vimercati R; Bruni R Haematologica; 1994; 79(3):218-24. PubMed ID: 7926970 [TBL] [Abstract][Full Text] [Related]
58. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia. Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052 [TBL] [Abstract][Full Text] [Related]
59. Activity of fludarabine in refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma--the Jerusalem experience. Gillis S; Dann EJ; Cass Y; Rochlemer RR; Polliack A Leuk Lymphoma; 1994 Sep; 15(1-2):173-5. PubMed ID: 7858497 [TBL] [Abstract][Full Text] [Related]
60. Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study. Mauro FR; Zinzani P; Zaja F; Gentile M; Vegna ML; Stefoni V; Marin L; Fanin R; Baccarani M; Tura S; Mandelli F Haematologica; 2003 Dec; 88(12):1348-57. PubMed ID: 14687987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]